Related Experiment Video
Updated: Aug 17, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Hsa_circ_0026344 suppresses gastric cancer progression via modulating the miR-1290/FBP2 axis
GaoChun Xiao1, TingTing Zhang2, BinBin Tan1
1Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, PR China.
Background:
Circular RNAs (circRNAs) are a novel type of noncoding RNAs and play important roles in tumorigenesis, including gastric cancer (GC). However, the functions of most circRNAs remain poorly understood. In our study, we mainly learn the influence of hsa_circ_0026344 (circ_0026344) in GC progression.
Methods:
Circ_0026344, miR-1290 and Fructose-1,6-bisphosphatase 2 (FBP2) expression was determined by quantitative real-time polymerase chain reaction (qRT-PCR). GC cell proliferation, migration, and invasion were detected by colony formation, 5-ethynyl-2'-deoxyuridine (EdU), and transwell assays, respectively. The interaction between circ_0026344 and miR-1290 complex was evaluated by RNA pull-down assay. The interaction of miR-1290 with circ_0026344 or FBP2 was detected using dual-luciferase reporter assay. A xenograft model was established to determine the effect of circ_0026344 on GC tumor growth in vivo.
Results:
Circ_0026344 expression was dramatically decreased in GC cells and tissues. Circ_0026344 overexpression inhibited GC cell proliferation, migration and invasion. MiR-1290 was predicted as a target of circ_0026344 and miR-1290 overexpression attenuated the anti-tumor effect of circ_0026344 on GC cells. Furthermore, we predicted FBP2 as the target of miR-1290. FBP2 knockdown reversed the effects of circ_0026344 knockdown on GC cell malignant behaviors. Functional analysis showed that circ_0026344 upregulated FBP2 expression via miR-1290. Additionally, in vivo studies demonstrated that circ_0026344 suppressed GC tumor progression.
Conclusion:
In conclusion, circ_0026344 inhibited GC cell proliferation via the miR-1290/FBP2 axis, which might provide a new therapeutic target for GC patients.
Insights
Circular RNA (circRNA) hsa_circ_0026344 inhibits gastric cancer (GC) progression by downregulating miR-1290 and upregulating Fructose-1,6-bisphosphatase 2 (FBP2). This circRNA may serve as a novel therapeutic target for GC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are emerging as critical regulators in tumorigenesis, particularly in gastric cancer (GC).
- The specific roles of most circRNAs, including hsa_circ_0026344 (circ_0026344), in GC progression are not well understood.
- This study investigates the functional impact of circ_0026344 on gastric cancer development.
Purpose of the Study:
- To elucidate the role of circ_0026344 in gastric cancer (GC) progression.
- To investigate the molecular mechanisms underlying circ_0026344's function in GC.
- To explore circ_0026344 as a potential therapeutic target for GC.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure circ_0026344, miR-1290, and Fructose-1,6-bisphosphatase 2 (FBP2) expression.
- Cellular assays including colony formation, 5-ethynyl-2'-deoxyuridine (EdU), and transwell assays were performed to assess GC cell proliferation, migration, and invasion.
- RNA pull-down and dual-luciferase reporter assays were employed to confirm interactions between circ_0026344, miR-1290, and FBP2. In vivo tumor growth was evaluated using a xenograft model.
Main Results:
- Circ_0026344 expression was significantly reduced in GC cells and tissues.
- Overexpression of circ_0026344 suppressed GC cell proliferation, migration, and invasion.
- Circ_0026344 inhibited GC progression by upregulating FBP2 expression through the miR-1290 sponge mechanism, as confirmed by in vitro and in vivo experiments.
Conclusions:
- Circ_0026344 functions as a tumor suppressor in gastric cancer.
- The identified circ_0026344/miR-1290/FBP2 axis provides a novel molecular mechanism in GC pathogenesis.
- Circ_0026344 holds promise as a potential therapeutic target for gastric cancer treatment.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
MicroRNAs
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...